Cargando…

May Measurement Month 2019: an analysis of blood pressure screening results from Kenya

Elevated blood pressure (BP) is the leading cause of global mortality, but control rates remain poor because most patients, especially in Africa, are unaware. May Measurement Month (MMM) is an annual global BP screening campaign that was initiated by the International Society of Hypertension (ISH) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogola, Elijah N, Mbau, Lilian, Gachemba, Yubrine M, Gitura, Bernard M, Barasa, Felix A, Nguchu, Hellen, Beaney, Thomas, Xia, Xin, Poulter, Neil R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141946/
https://www.ncbi.nlm.nih.gov/pubmed/34054367
http://dx.doi.org/10.1093/eurheartj/suab040
_version_ 1783696474268237824
author Ogola, Elijah N
Mbau, Lilian
Gachemba, Yubrine M
Gitura, Bernard M
Barasa, Felix A
Nguchu, Hellen
Beaney, Thomas
Xia, Xin
Poulter, Neil R
author_facet Ogola, Elijah N
Mbau, Lilian
Gachemba, Yubrine M
Gitura, Bernard M
Barasa, Felix A
Nguchu, Hellen
Beaney, Thomas
Xia, Xin
Poulter, Neil R
author_sort Ogola, Elijah N
collection PubMed
description Elevated blood pressure (BP) is the leading cause of global mortality, but control rates remain poor because most patients, especially in Africa, are unaware. May Measurement Month (MMM) is an annual global BP screening campaign that was initiated by the International Society of Hypertension (ISH) in 2017 to raise awareness of raised BP. Following participation in 2017 and 2018, Kenya participated again in 2019 and the results are reported here. Screening was carried out in 30 sites by volunteers coordinated by the Kenya Cardiac Society. Participants had three BP readings by standard methods with the last two being averaged and recorded. Heart rate, weight, height, socio-demographic parameters, and co-morbidities were documented. Hypertension was defined as a systolic BP (SBP) ≥140 mmHg and/or a diastolic BP (DBP) ≥90 mmHg or being on treatment with at least one antihypertensive medication. A total of 33 992 participants were screened, mean age was 42.5 (SD 16.8) years and 58.7% of participants were female. Only 27.3% had their BPs checked within the preceding 12 months. After multiple imputation, 26.1% were hypertensive, of whom 34.5% were aware of their hypertension and 31.5% were on treatment. Of those on treatment, 59.7% were controlled translating to 18.8% of all hypertensives. Being on treatment for hypertension, overweight, obese or having had hypertension in previous pregnancy were associated with increased SBP and DBP, while diabetes was associated with raised SBP. Two-thirds of hypertensives were unaware. Only a third of those aware were on treatment, with about 60% of these controlled. Lack of awareness remains a significant barrier to BP control. Programmes to raise awareness such as MMM are significant in raising population awareness.
format Online
Article
Text
id pubmed-8141946
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81419462021-05-27 May Measurement Month 2019: an analysis of blood pressure screening results from Kenya Ogola, Elijah N Mbau, Lilian Gachemba, Yubrine M Gitura, Bernard M Barasa, Felix A Nguchu, Hellen Beaney, Thomas Xia, Xin Poulter, Neil R Eur Heart J Suppl Articles Elevated blood pressure (BP) is the leading cause of global mortality, but control rates remain poor because most patients, especially in Africa, are unaware. May Measurement Month (MMM) is an annual global BP screening campaign that was initiated by the International Society of Hypertension (ISH) in 2017 to raise awareness of raised BP. Following participation in 2017 and 2018, Kenya participated again in 2019 and the results are reported here. Screening was carried out in 30 sites by volunteers coordinated by the Kenya Cardiac Society. Participants had three BP readings by standard methods with the last two being averaged and recorded. Heart rate, weight, height, socio-demographic parameters, and co-morbidities were documented. Hypertension was defined as a systolic BP (SBP) ≥140 mmHg and/or a diastolic BP (DBP) ≥90 mmHg or being on treatment with at least one antihypertensive medication. A total of 33 992 participants were screened, mean age was 42.5 (SD 16.8) years and 58.7% of participants were female. Only 27.3% had their BPs checked within the preceding 12 months. After multiple imputation, 26.1% were hypertensive, of whom 34.5% were aware of their hypertension and 31.5% were on treatment. Of those on treatment, 59.7% were controlled translating to 18.8% of all hypertensives. Being on treatment for hypertension, overweight, obese or having had hypertension in previous pregnancy were associated with increased SBP and DBP, while diabetes was associated with raised SBP. Two-thirds of hypertensives were unaware. Only a third of those aware were on treatment, with about 60% of these controlled. Lack of awareness remains a significant barrier to BP control. Programmes to raise awareness such as MMM are significant in raising population awareness. Oxford University Press 2021-05-20 /pmc/articles/PMC8141946/ /pubmed/34054367 http://dx.doi.org/10.1093/eurheartj/suab040 Text en Published on behalf of the European Society of Cardiology. © The Author(s) 2021. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Articles
Ogola, Elijah N
Mbau, Lilian
Gachemba, Yubrine M
Gitura, Bernard M
Barasa, Felix A
Nguchu, Hellen
Beaney, Thomas
Xia, Xin
Poulter, Neil R
May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title_full May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title_fullStr May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title_full_unstemmed May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title_short May Measurement Month 2019: an analysis of blood pressure screening results from Kenya
title_sort may measurement month 2019: an analysis of blood pressure screening results from kenya
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141946/
https://www.ncbi.nlm.nih.gov/pubmed/34054367
http://dx.doi.org/10.1093/eurheartj/suab040
work_keys_str_mv AT ogolaelijahn maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT mbaulilian maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT gachembayubrinem maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT giturabernardm maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT barasafelixa maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT nguchuhellen maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT beaneythomas maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT xiaxin maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya
AT poulterneilr maymeasurementmonth2019ananalysisofbloodpressurescreeningresultsfromkenya